glp-1 telehealth crackdown news today FDA takes aim at companies for promoting unofficial weight loss drug dupes New project announcement: HHS‑OIG is

J Hepatol (2019) 70:53144

In essence, Retatrutide tackles three metabolic pathways at once, resulting in greater efficacy in lowering blood glucose and body fat than single- or dual-agonist therapies

First, a quick refresher on what a GLP-1 receptor agonist is: one of the most popular GLP-1 receptor agonists is Ozempic, a semaglutide medication that's technically designed to help control blood sugar in people with type 2 diabetes

reported that semaglutide accessed the brainstem, hypothalamus, and the dorsal half of the septal area, largely via small circumventricular organs, but it was not shown to cross the BBB [27]